Lotus Eye Hospital & Institute (BOM:532998) Median PS Value: ₹67.77 (As of Jul. 07, 2026) — 3958% Above Median


BOM:532998 Lotus Eye Hospital & Institute Ltd BOM:532998
71 GF Score
Price ₹122.65
GF Value ₹91.95
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Lotus Eye Hospital & Institute Median PS Value?

Lotus Eye Hospital & Institute BOM:532998 -5.40% 71 Median PS Value is ₹67.77 as of Jul. 07, 2026, which is 100% below its 10-year median of 1.67. GuruFocus rates BOM:532998 with a GF Score™ of 71/100 and a GF Value™ of ₹91.95 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 263 Healthcare Providers & Services companies, Lotus Eye Hospital & Institute ranks worse than 93.16% on this metric.

This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Lotus Eye Hospital & Institute's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was ₹26.353. Lotus Eye Hospital & Institute's 10-Year median PS Ratio is 2.5716. Therefore, the Median PS Value for today is ₹67.77.

As of today (2026-07-07), Lotus Eye Hospital & Institute's share price is ₹122.65. Lotus Eye Hospital & Institute's Median PS Value is ₹67.77. Therefore, Lotus Eye Hospital & Institute's Price to Median PS Value for today is 1.81.

The historical rank and industry rank for Lotus Eye Hospital & Institute's Median PS Value or its related term are showing as below:

BOM:532998' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 1.45   Med: 1.67   Max: 2.34
Current: 1.81

During the past 13 years, the highest Price to Median PS Value of Lotus Eye Hospital & Institute was 2.34. The lowest was 1.45. And the median was 1.67.

BOM:532998's Price-to-Median-PS-Value is ranked worse than
93.16% of 263 companies
in the Healthcare Providers & Services industry
Industry Median: 0.71 vs BOM:532998: 1.81

Lotus Eye Hospital & Institute  (BOM:532998) Median PS Value Explanation

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.

Lotus Eye Hospital & Institute's Price to Median PS Value for today is calculated as

Price to Median PS Value=Share Price/Median PS Value
=122.65/67.77
=1.81

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lotus Eye Hospital & Institute Median PS Value Related Terms


Lotus Eye Hospital & Institute Median PS Value Historical Data

* Premium members only.

The historical data trend for Lotus Eye Hospital & Institute's Median PS Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lotus Eye Hospital & Institute Median PS Value Chart

Lotus Eye Hospital & Institute Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Median PS Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 22.81 31.80 38.12 48.25 67.77

Lotus Eye Hospital & Institute Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Median PS Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 48.25 51.70 55.70 62.72 67.77

BOM:532998 vs HCA, THC, DVA: Median PS Value Comparison

For the Medical Care Facilities subindustry, Lotus Eye Hospital & Institute's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lotus Eye Hospital & Institute Price-to-Median-PS-Value vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Lotus Eye Hospital & Institute's Price-to-Median-PS-Value distribution charts can be found below:

* The bar in red indicates where Lotus Eye Hospital & Institute's Price-to-Median-PS-Value falls into.


BOM:532998
71GF Score
Lotus Eye Hospital & Institute Ltd BOM:532998
Median PS Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Lotus Eye Hospital & Institute Median PS Value Calculation

Lotus Eye Hospital & Institute's Median PS Value for today is calculated as

Median PS Value=Revenue per Share (TTM)*10-Year Median PS Ratio
=26.353*2.5716
=67.77

10-Year Median PS Ratio is 2.5716.
Lotus Eye Hospital & Institute's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹26.353.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Median PS Value →
What does a Median PS Value of ₹67.77 mean?
Lotus Eye Hospital & Institute (BOM:532998) has a Median PS Value of ₹67.77 as of Jul. 07, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Lotus Eye Hospital & Institute and its competitors. This is 3958% above median its historical median of 1.67. Over the past decade, Lotus Eye Hospital & Institute's Median PS Value has ranged from 1.45 to 2.34. According to the industry distribution chart, Lotus Eye Hospital & Institute ranks #245 out of 263 companies in the Healthcare Providers & Services industry, placing it in the top 93.2%.
Is Lotus Eye Hospital & Institute's Median PS Value too high?
Lotus Eye Hospital & Institute's current Median PS Value of ₹67.77 is 3958% above median its 10-year median of 1.67. Over the past 10 years, this metric has ranged from a low of 1.45 to a high of 2.34. Based on the distribution chart, Lotus Eye Hospital & Institute ranks #245 out of 263 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Lotus Eye Hospital & Institute has a GF Score™ of 71/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Lotus Eye Hospital & Institute's Median PS Value compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Lotus Eye Hospital & Institute ranks #245 out of 263 companies for Median PS Value. This places Lotus Eye Hospital & Institute in the lower half of its industry. The industry median Median PS Value is 0.71. Historically, Lotus Eye Hospital & Institute's own Median PS Value has ranged from 1.45 to 2.34 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Healthcare Providers & Services company?
The median Median PS Value among Healthcare Providers & Services companies is 0.71, based on 263 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Lotus Eye Hospital & Institute and its competitors. For the Healthcare Providers & Services industry, the median Median PS Value is 0.71 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Lotus Eye Hospital & Institute's current Median PS Value is ₹67.77, which is 3958% above median its own 10-year median of 1.67. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lotus Eye Hospital & Institute stock overvalued right now?
Based on GuruFocus' analysis, Lotus Eye Hospital & Institute (BOM:532998) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹91.95, compared to a current price of ₹122.65 — trading 33.4% above its estimated fair value. The current Median PS Value is ₹67.77, which is 3958% above median its 10-year median of 1.67. Lotus Eye Hospital & Institute's overall GF Score™ is 71/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For Lotus Eye Hospital & Institute (BOM:532998), the current Median PS Value is ₹67.77 as of Jul. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Lotus Eye Hospital & Institute (BOM:532998) Overvalued in 2026?

Based on GuruFocus' analysis, Lotus Eye Hospital & Institute stock appears to be overvalued. The current stock price of ₹122.65 is trading 33.4% above its estimated GF Value™ of ₹91.95. GuruFocus considers Lotus Eye Hospital & Institute to be Significantly Overvalued.

Key valuation signals for BOM:532998:

  • Median PS Value: ₹67.77 (3958% above median its 10-year median of 1.67)
  • GF Value™: ₹91.95 vs. price of ₹122.65 (33.4% above fair value)
  • GF Score™: 71/100 with 4 warning signs

No single metric tells the full story. See the BOM:532998 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Lotus Eye Hospital & Institute Business Description

Other Exchanges LOTUSEYE:India
Address SF No. 770/12, Avinashi Road, Civil Aerodrome Post, Coimbatore, TN, IND, 641 014
Lotus Eye Hospital & Institute Ltd is an India-based eye care hospital. It is engaged in providing treatment and care for eye diseases and disorders. It offers treatment services for eye conditions like refractive error, retina and uvea, cornea, glaucoma, pediatric, orbit and oculoplasty, neuro-ophthalmology, and binocular vision. In addition, the company also operates an eye bank for functioning eye donation activities. The company mainly operates in India and generates revenue by providing medical services, pharmacy sales, contact lenses, and optical, of which the majority of the revenue is derived from providing segmmedical services.
71GF Score

Get the complete analysis for BOM:532998

Median PS Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹122.65
Price
₹91.95
GF Value